The Cancer Genome Atlas (TCGA) datasets (TCGA 2012 provisional; cbioportal.org) showed that NEDD4L levels were downregulated in multiple human tumor patients, and were inversely correlated with clinical outcome. This evidence concerns the gene NEDD4L and neoplasm.